RanBP1: A Potential Therapeutic Target for Cancer Stem Cells in Lung Cancer and Glioma

Cancer stem cells (CSCs) are known to be one of the factors that make cancer treatment difficult. Many researchers are thus conducting research to efficiently destroy CSCs. Therefore, we sought to suggest a new target that can efficiently suppress CSCs. In this study, we observed a high expression o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular sciences 2023-04, Vol.24 (7), p.6855
Hauptverfasser: Kahm, Yeon-Jee, Kim, In-Gyu, Kim, Rae-Kwon
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 7
container_start_page 6855
container_title International journal of molecular sciences
container_volume 24
creator Kahm, Yeon-Jee
Kim, In-Gyu
Kim, Rae-Kwon
description Cancer stem cells (CSCs) are known to be one of the factors that make cancer treatment difficult. Many researchers are thus conducting research to efficiently destroy CSCs. Therefore, we sought to suggest a new target that can efficiently suppress CSCs. In this study, we observed a high expression of Ran-binding protein 1 (RanBP1) in lung cancer stem cells (LCSCs) and glioma stem cells (GSCs). Upregulated RanBP1 expression is strongly associated with the expression of CSC marker proteins and CSC regulators. In addition, an elevated RanBP1 expression is strongly associated with a poor patient prognosis. CSCs have the ability to resist radiation, and RanBP1 regulates this ability. RanBP1 also affects the metastasis-associated epithelial-mesenchymal transition (EMT) phenomenon. EMT marker proteins and regulatory proteins are affected by RanBP1 expression, and cell motility was regulated according to RanBP1 expression. The cancer microenvironment influences cancer growth, metastasis, and cancer treatment. RanBP1 can modulate the cancer microenvironment by regulating the cytokine IL-18. Secreted IL-18 acts on cancer cells and promotes cancer malignancy. Our results reveal, for the first time, that RanBP1 is an important regulator in LCSCs and GSCs, suggesting that it holds potential for use as a potential therapeutic target.
doi_str_mv 10.3390/ijms24076855
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10095367</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A751927888</galeid><sourcerecordid>A751927888</sourcerecordid><originalsourceid>FETCH-LOGICAL-c480t-534c813705cdbbe20a2df60d8fa332464eea7d732ce315b4fc186b15d78c14e13</originalsourceid><addsrcrecordid>eNptksuPFCEQxonRuA-9eTYkXjzsrDwb8GLGia4mk7jR0Suh6epZJt0wQreJ_71s9uGsMRwg1K--4isKoReUnHNuyJuwGwsTRDVaykfomArGFoQ06vHB-QidlLIjhHEmzVN0xBURSrPmGP346uL7S_oWL_FlmiBOwQ14cwXZ7WGegscbl7cw4T5lvHLRQ8bfJhjxCoah4BDxeo7bu4iLHb4YQhrdM_Skd0OB57f7Kfr-8cNm9Wmx_nLxebVcL7zQZFpILrym9TXSd20LjDjW9Q3pdO84Z6IRAE51ijMPnMpW9J7qpqWyU9pTAZSfonc3uvu5HaHz1UB2g93nMLr82yYX7MNIDFd2m35ZSoiRvFFV4fWtQk4_ZyiTHUPx1Z2LkOZima4NZFQSU9FX_6C7NOdY_VmmjGm0MZr9pbZuABtin2phfy1ql0pSw5TWulLn_6Hq6mAMPkXoQ71_kHB2k-BzKiVDf2-SEns9CPZwECr-8rAx9_Ddz_M_1tyr1Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2799689982</pqid></control><display><type>article</type><title>RanBP1: A Potential Therapeutic Target for Cancer Stem Cells in Lung Cancer and Glioma</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Kahm, Yeon-Jee ; Kim, In-Gyu ; Kim, Rae-Kwon</creator><creatorcontrib>Kahm, Yeon-Jee ; Kim, In-Gyu ; Kim, Rae-Kwon</creatorcontrib><description>Cancer stem cells (CSCs) are known to be one of the factors that make cancer treatment difficult. Many researchers are thus conducting research to efficiently destroy CSCs. Therefore, we sought to suggest a new target that can efficiently suppress CSCs. In this study, we observed a high expression of Ran-binding protein 1 (RanBP1) in lung cancer stem cells (LCSCs) and glioma stem cells (GSCs). Upregulated RanBP1 expression is strongly associated with the expression of CSC marker proteins and CSC regulators. In addition, an elevated RanBP1 expression is strongly associated with a poor patient prognosis. CSCs have the ability to resist radiation, and RanBP1 regulates this ability. RanBP1 also affects the metastasis-associated epithelial-mesenchymal transition (EMT) phenomenon. EMT marker proteins and regulatory proteins are affected by RanBP1 expression, and cell motility was regulated according to RanBP1 expression. The cancer microenvironment influences cancer growth, metastasis, and cancer treatment. RanBP1 can modulate the cancer microenvironment by regulating the cytokine IL-18. Secreted IL-18 acts on cancer cells and promotes cancer malignancy. Our results reveal, for the first time, that RanBP1 is an important regulator in LCSCs and GSCs, suggesting that it holds potential for use as a potential therapeutic target.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms24076855</identifier><identifier>PMID: 37047826</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Antibodies ; Cancer ; Care and treatment ; Cell adhesion &amp; migration ; Cell Line, Tumor ; Cytokines ; Epithelial-Mesenchymal Transition ; Gene expression ; Glioma ; Glioma - metabolism ; Glioma cells ; Gliomas ; Health aspects ; Humans ; Interleukin 18 ; Interleukin-18 - metabolism ; Lung cancer ; Lung Neoplasms - metabolism ; Malignancy ; Metastases ; Metastasis ; Microenvironments ; Motility ; Neoplastic Stem Cells - metabolism ; Oncology, Experimental ; Protein binding ; Protein expression ; Proteins ; Radiation ; Ran-binding protein ; Regulatory proteins ; Scientific equipment and supplies industry ; Spheres ; Stem cells ; Therapeutic applications ; Therapeutic targets ; Tumor Microenvironment</subject><ispartof>International journal of molecular sciences, 2023-04, Vol.24 (7), p.6855</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c480t-534c813705cdbbe20a2df60d8fa332464eea7d732ce315b4fc186b15d78c14e13</citedby><cites>FETCH-LOGICAL-c480t-534c813705cdbbe20a2df60d8fa332464eea7d732ce315b4fc186b15d78c14e13</cites><orcidid>0000-0001-6607-4449 ; 0000-0002-5102-8885</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095367/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095367/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37047826$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kahm, Yeon-Jee</creatorcontrib><creatorcontrib>Kim, In-Gyu</creatorcontrib><creatorcontrib>Kim, Rae-Kwon</creatorcontrib><title>RanBP1: A Potential Therapeutic Target for Cancer Stem Cells in Lung Cancer and Glioma</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Cancer stem cells (CSCs) are known to be one of the factors that make cancer treatment difficult. Many researchers are thus conducting research to efficiently destroy CSCs. Therefore, we sought to suggest a new target that can efficiently suppress CSCs. In this study, we observed a high expression of Ran-binding protein 1 (RanBP1) in lung cancer stem cells (LCSCs) and glioma stem cells (GSCs). Upregulated RanBP1 expression is strongly associated with the expression of CSC marker proteins and CSC regulators. In addition, an elevated RanBP1 expression is strongly associated with a poor patient prognosis. CSCs have the ability to resist radiation, and RanBP1 regulates this ability. RanBP1 also affects the metastasis-associated epithelial-mesenchymal transition (EMT) phenomenon. EMT marker proteins and regulatory proteins are affected by RanBP1 expression, and cell motility was regulated according to RanBP1 expression. The cancer microenvironment influences cancer growth, metastasis, and cancer treatment. RanBP1 can modulate the cancer microenvironment by regulating the cytokine IL-18. Secreted IL-18 acts on cancer cells and promotes cancer malignancy. Our results reveal, for the first time, that RanBP1 is an important regulator in LCSCs and GSCs, suggesting that it holds potential for use as a potential therapeutic target.</description><subject>Antibodies</subject><subject>Cancer</subject><subject>Care and treatment</subject><subject>Cell adhesion &amp; migration</subject><subject>Cell Line, Tumor</subject><subject>Cytokines</subject><subject>Epithelial-Mesenchymal Transition</subject><subject>Gene expression</subject><subject>Glioma</subject><subject>Glioma - metabolism</subject><subject>Glioma cells</subject><subject>Gliomas</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Interleukin 18</subject><subject>Interleukin-18 - metabolism</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - metabolism</subject><subject>Malignancy</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Microenvironments</subject><subject>Motility</subject><subject>Neoplastic Stem Cells - metabolism</subject><subject>Oncology, Experimental</subject><subject>Protein binding</subject><subject>Protein expression</subject><subject>Proteins</subject><subject>Radiation</subject><subject>Ran-binding protein</subject><subject>Regulatory proteins</subject><subject>Scientific equipment and supplies industry</subject><subject>Spheres</subject><subject>Stem cells</subject><subject>Therapeutic applications</subject><subject>Therapeutic targets</subject><subject>Tumor Microenvironment</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptksuPFCEQxonRuA-9eTYkXjzsrDwb8GLGia4mk7jR0Suh6epZJt0wQreJ_71s9uGsMRwg1K--4isKoReUnHNuyJuwGwsTRDVaykfomArGFoQ06vHB-QidlLIjhHEmzVN0xBURSrPmGP346uL7S_oWL_FlmiBOwQ14cwXZ7WGegscbl7cw4T5lvHLRQ8bfJhjxCoah4BDxeo7bu4iLHb4YQhrdM_Skd0OB57f7Kfr-8cNm9Wmx_nLxebVcL7zQZFpILrym9TXSd20LjDjW9Q3pdO84Z6IRAE51ijMPnMpW9J7qpqWyU9pTAZSfonc3uvu5HaHz1UB2g93nMLr82yYX7MNIDFd2m35ZSoiRvFFV4fWtQk4_ZyiTHUPx1Z2LkOZima4NZFQSU9FX_6C7NOdY_VmmjGm0MZr9pbZuABtin2phfy1ql0pSw5TWulLn_6Hq6mAMPkXoQ71_kHB2k-BzKiVDf2-SEns9CPZwECr-8rAx9_Ddz_M_1tyr1Q</recordid><startdate>20230401</startdate><enddate>20230401</enddate><creator>Kahm, Yeon-Jee</creator><creator>Kim, In-Gyu</creator><creator>Kim, Rae-Kwon</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6607-4449</orcidid><orcidid>https://orcid.org/0000-0002-5102-8885</orcidid></search><sort><creationdate>20230401</creationdate><title>RanBP1: A Potential Therapeutic Target for Cancer Stem Cells in Lung Cancer and Glioma</title><author>Kahm, Yeon-Jee ; Kim, In-Gyu ; Kim, Rae-Kwon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c480t-534c813705cdbbe20a2df60d8fa332464eea7d732ce315b4fc186b15d78c14e13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antibodies</topic><topic>Cancer</topic><topic>Care and treatment</topic><topic>Cell adhesion &amp; migration</topic><topic>Cell Line, Tumor</topic><topic>Cytokines</topic><topic>Epithelial-Mesenchymal Transition</topic><topic>Gene expression</topic><topic>Glioma</topic><topic>Glioma - metabolism</topic><topic>Glioma cells</topic><topic>Gliomas</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Interleukin 18</topic><topic>Interleukin-18 - metabolism</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - metabolism</topic><topic>Malignancy</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Microenvironments</topic><topic>Motility</topic><topic>Neoplastic Stem Cells - metabolism</topic><topic>Oncology, Experimental</topic><topic>Protein binding</topic><topic>Protein expression</topic><topic>Proteins</topic><topic>Radiation</topic><topic>Ran-binding protein</topic><topic>Regulatory proteins</topic><topic>Scientific equipment and supplies industry</topic><topic>Spheres</topic><topic>Stem cells</topic><topic>Therapeutic applications</topic><topic>Therapeutic targets</topic><topic>Tumor Microenvironment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kahm, Yeon-Jee</creatorcontrib><creatorcontrib>Kim, In-Gyu</creatorcontrib><creatorcontrib>Kim, Rae-Kwon</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kahm, Yeon-Jee</au><au>Kim, In-Gyu</au><au>Kim, Rae-Kwon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RanBP1: A Potential Therapeutic Target for Cancer Stem Cells in Lung Cancer and Glioma</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2023-04-01</date><risdate>2023</risdate><volume>24</volume><issue>7</issue><spage>6855</spage><pages>6855-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Cancer stem cells (CSCs) are known to be one of the factors that make cancer treatment difficult. Many researchers are thus conducting research to efficiently destroy CSCs. Therefore, we sought to suggest a new target that can efficiently suppress CSCs. In this study, we observed a high expression of Ran-binding protein 1 (RanBP1) in lung cancer stem cells (LCSCs) and glioma stem cells (GSCs). Upregulated RanBP1 expression is strongly associated with the expression of CSC marker proteins and CSC regulators. In addition, an elevated RanBP1 expression is strongly associated with a poor patient prognosis. CSCs have the ability to resist radiation, and RanBP1 regulates this ability. RanBP1 also affects the metastasis-associated epithelial-mesenchymal transition (EMT) phenomenon. EMT marker proteins and regulatory proteins are affected by RanBP1 expression, and cell motility was regulated according to RanBP1 expression. The cancer microenvironment influences cancer growth, metastasis, and cancer treatment. RanBP1 can modulate the cancer microenvironment by regulating the cytokine IL-18. Secreted IL-18 acts on cancer cells and promotes cancer malignancy. Our results reveal, for the first time, that RanBP1 is an important regulator in LCSCs and GSCs, suggesting that it holds potential for use as a potential therapeutic target.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>37047826</pmid><doi>10.3390/ijms24076855</doi><orcidid>https://orcid.org/0000-0001-6607-4449</orcidid><orcidid>https://orcid.org/0000-0002-5102-8885</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2023-04, Vol.24 (7), p.6855
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10095367
source MDPI - Multidisciplinary Digital Publishing Institute; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Antibodies
Cancer
Care and treatment
Cell adhesion & migration
Cell Line, Tumor
Cytokines
Epithelial-Mesenchymal Transition
Gene expression
Glioma
Glioma - metabolism
Glioma cells
Gliomas
Health aspects
Humans
Interleukin 18
Interleukin-18 - metabolism
Lung cancer
Lung Neoplasms - metabolism
Malignancy
Metastases
Metastasis
Microenvironments
Motility
Neoplastic Stem Cells - metabolism
Oncology, Experimental
Protein binding
Protein expression
Proteins
Radiation
Ran-binding protein
Regulatory proteins
Scientific equipment and supplies industry
Spheres
Stem cells
Therapeutic applications
Therapeutic targets
Tumor Microenvironment
title RanBP1: A Potential Therapeutic Target for Cancer Stem Cells in Lung Cancer and Glioma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T02%3A41%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RanBP1:%20A%20Potential%20Therapeutic%20Target%20for%20Cancer%20Stem%20Cells%20in%20Lung%20Cancer%20and%20Glioma&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Kahm,%20Yeon-Jee&rft.date=2023-04-01&rft.volume=24&rft.issue=7&rft.spage=6855&rft.pages=6855-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms24076855&rft_dat=%3Cgale_pubme%3EA751927888%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2799689982&rft_id=info:pmid/37047826&rft_galeid=A751927888&rfr_iscdi=true